Perineural Injection Therapy Training for Pharmacists

Perineural injection therapy (PIT) involves the subcutaneous injection of a low-concentration buffered dextrose solution (typically 5% dextrose) along the course of superficial peripheral nerves that have become chronically irritated and inflamed. The dextrose interacts with TRPV1 receptors on sensory nerve fibers, reducing neurogenic inflammation and restoring normal nerve function. This mechanism addresses the underlying neural dysfunction rather than simply masking pain.

PIT has demonstrated clinical efficacy for chronic neuropathic pain conditions including headaches and migraines, chronic neck and back pain, lateral epicondylitis, Achilles tendinopathy, knee pain, post-surgical pain syndromes, and various other chronic musculoskeletal pain conditions that have a significant neuropathic component. It is particularly valuable for patients who have not responded adequately to conventional pain treatments.

Most patients require a series of four to eight treatment sessions spaced one to two weeks apart, though significant pain reduction is often noticed after the first two to three treatments. Some chronic conditions may require additional maintenance sessions. The course teaches you how to structure multi-session treatment protocols and track clinical outcomes to guide treatment duration.

PIT has an excellent safety profile because the injections are performed subcutaneously (not deep) using a very low-concentration dextrose solution rather than corticosteroids or other medications with systemic side effects. The most common side effect is mild, temporary discomfort at injection sites. The superficial injection depth and benign injectate make PIT one of the safest interventional pain procedures available.

Traditional prolotherapy (regenerative injection therapy) uses higher-concentration dextrose solutions (typically 15-25%) injected into ligament and tendon attachments to stimulate a healing inflammatory response. Perineural injection therapy uses much lower concentrations (5%) injected subcutaneously along superficial nerve pathways to reduce neurogenic inflammation. The targets, mechanisms, and concentrations are distinctly different despite both using dextrose.

Yes, PIT integrates well with other pain management modalities including joint injections, trigger point injections, physical therapy, regenerative medicine treatments, and chiropractic care. Many practitioners use PIT as part of a comprehensive, multi-modal pain management approach that addresses both neuropathic and nociceptive pain components simultaneously.

PIT requires minimal equipment — small gauge needles (typically 27-30 gauge), sterile buffered dextrose solution, syringes, and standard injection supplies. The low equipment cost and absence of expensive imaging or specialized devices make PIT one of the most accessible interventional pain procedures to add to a practice, with virtually no barrier to entry beyond proper training.

Yes, Empire Medical Training's Perineural Injection Therapy Training is fully CME/CE accredited. You receive certification documenting your training in PIT techniques along with earned CME/CE credits applicable to license renewal and professional development requirements for your specific healthcare profession.

PIT uses a simple buffered dextrose solution injected subcutaneously — making it one of the safest and most technically accessible interventional procedures. There are no complex pharmaceuticals requiring titration, no deep injections with vascular risk, and minimal side effects. For pharmacists expanding into clinical procedures, PIT provides an ideal combination of clinical effectiveness and procedural accessibility.

Your understanding of TRPV1 receptor pharmacology provides insight into PIT's mechanism of action. Your solution preparation and compounding skills apply directly to optimizing dextrose concentration and pH buffering for PIT formulations. Your quality assurance training ensures consistent treatment solution preparation. These pharmacy competencies enhance your PIT practice in ways unique to your profession.

Pharmacist authority for performing PIT depends on state regulations and practice arrangements. The subcutaneous injection technique and benign injectate make PIT among the most accessible procedures for pharmacists in collaborative practice settings. As pharmacist clinical authority expands, PIT's safety profile positions it as one of the first procedural techniques likely to fall within evolving pharmacist scope.

Pharmacist scope of practice for administering injectable aesthetic treatments varies by state. Some states explicitly authorize pharmacist-administered injectables, while others require collaborative practice agreements or additional certifications. The trend is toward expanding pharmacist clinical authority. We recommend checking your state pharmacy board's current regulations. Empire's certification provides the documented training that state boards and credentialing organizations require.

Pharmacists bring an unparalleled understanding of drug pharmacology, interactions, contraindications, and safety profiles to procedural medicine. This knowledge translates directly to superior product selection, accurate dosing calculations, thorough patient screening, and enhanced safety management during injectable procedures. Patients and referring physicians value having a provider who understands the science behind the products at a molecular level.

Pharmacists with procedural certification can work in medical spas, aesthetic clinics, pain management practices, compounding pharmacies that offer clinical services, integrative medicine centers, and collaborative practice settings. Some pharmacist entrepreneurs have opened their own aesthetic and wellness clinics. The combination of clinical pharmacy expertise and procedural skills creates a unique professional profile with growing demand across multiple healthcare sectors.